New data show HARMONY Alliance’s big data platform can improve the prognostic tool for myeloma patientsMPE, MyelomaDecember 6, 2019
The European Medicines Agency (EMA) recommends extension of indications for daratumumabAccess, MyelomaOctober 21, 2019
European Commission approves elotuzumab plus pomalidomide and dexamethasone for relapsed and refractory myelomaAccess, MyelomaAugust 28, 2019
Janssen seeks European marketing authorisation for subcutaneous (under the skin) daratumumab (Darzalex®)Access, MyelomaJuly 19, 2019
HARMONY reaches milestone capturing data from 45,000 patients with blood cancersMPE, MyelomaJune 25, 2019
